Heart Disease Journals

Cardiology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bisoendial RJ et al. – A review detailing the pathophysiology of cardiovascular risk in RA patients. Statins have a dual effect in RA patients (lipid-lowering and immune modulation). Optimal guidelines for cardiovascular risk reduction in RA patients are lacking.

Related Articles

Statin-independent prognosis of patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy
Annals of Oncology, 11/06/09    Relevance Score: 68%

Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09    Relevance Score: 68%

Statin prophylaxis and inflammatory mediators following cardiopulmonary bypass: a systematic review
Critical Care, 10/27/09    Relevance Score: 68%

Are High-Risk Hypertensive Patients being Prescribed Concomitant Statin Therapy?: A Retrospective Cohort Study
American Journal of Cardiovascular Drugs, 10/07/09    Relevance Score: 68%

Statin therapy initiated in a man with hepatitis C and elevated cholesterol
The Clinical Advisor, 10/07/09    Relevance Score: 67%

Today in Clinical Pharmacology...keeping you current

Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review
The American Journal of Geriatric Pharmacotherapy, 12/18/09

Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study
Age and Aging, 12/18/09

Role of coenzyme Q10 in cardiac disease, hypertension and Meniere-like syndrome
Pharmacology & Therapeutics, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address